Search

everythinglearnresearchcommunity

for

Search:↓

Researchers found four genes that could help diagnose severe alopecia areata early.

Conditioned media from mesenchymal stem cells show promise for tissue repair and disease treatment, but more research is needed on their safety and effectiveness.

The research reveals how early embryonic mouse skin develops from simple to complex structures, identifying various cell types and their roles in this process.

Blocking Rab27a slows hair growth, while blocking Rab27b encourages it.

Blocking EGFR in skin cells doesn't majorly increase inflammation markers.

SCD-153 shows promise as an effective topical treatment for alopecia areata.

Topical vitamin D is effective in treating vitiligo with few side effects.

EPDS and MS might share an immune-related cause.

The conclusion is that analyzing RNA from skin oils is a promising way to understand skin diseases.

Genes related to keratin, skin cell differentiation, and immune functions are key in hedgehog skin and spine development.

Higher granulysin levels in the blood are linked to more severe hair loss in alopecia areata patients, and these levels decrease after effective treatment.

TNF-alpha inhibitors can cause various immune-related skin issues.

Erdr1 could be a new marker for diagnosing hair loss.

New treatments for hair loss show promise but need more research to confirm safety and effectiveness.

2011 dermatological research found new skin aging markers, hair loss causes, skin defense mechanisms, and potential for new treatments.

Activating TLR5 in the gut can extend lifespan and improve health in aged mice.

Single-cell engineered biotherapeutics show promise for skin treatment but need more research and trials.

Pantethine may boost the immune system's ability to fight sarcoma.

Certain genetic variants linked to immune response increase the risk of alopecia areata in Taiwanese people.

Skin cell types develop when specific genes are turned on by removing certain chemical tags from DNA.

Apremilast shows promise for several skin conditions but needs more research.

Using microneedling with PRP improves skin and hair conditions more than microneedling alone.

A new mutation in the TMEM173 gene and a risk allele in IFIH1 cause a unique set of immune-related symptoms.

The symposium highlighted the importance of understanding disease mechanisms for targeted dermatology treatments.

Fzd2 is important for skin and hair development through various signaling ways.

Oral tofacitinib significantly improves lichen planopilaris symptoms without adverse effects.

Tofacitinib helped most patients with alopecia areata regrow hair and changes in immune cells were linked to the treatment's effectiveness.

Hair loss in Androgenetic alopecia (AGA) is due to altered cell sensitivity to hormones, not increased hormone levels. Hair growth periods shorten over time, causing hair to become thinner and shorter. This is linked to miscommunication between cell pathways in hair follicles. There's also a change in gene expression related to blood vessels and cell growth in balding hair follicles. The exact molecular causes of AGA are still unclear.

Stopping S100A3 activity slows down hair growth in mice.

Finding functions for unknown GPCRs is hard but key for making new drugs.